Psychiatry General
Jan 07, 2021
: Bipolar disorder (BD) is a severe mental condition with a lifetime prevalence estimated around 2% among the general population. Due to risk factors, etiological mechanisms, and the chronic use of ps...
Jan 07, 2021
Neural abnormalities in emotional response inhibition still exist in the euthymic phase of bipolar disorder (BD). Few studies on comparisons of functional magnetic resonance imaging (fMRI) manifestati...
Jan 07, 2021
Adolescence often is characterized by the onset of social anxiety and risk taking; yet, not all youth are anxious and/or risk takers. There are several factors that may help differentiate youth with a...
Jan 07, 2021
Residual insomnia is associated with a risk of depression recurrence.In this retrospective, longitudinal cohort study, the recurrence pattern of depression in patients with or without residual insomni...
Jan 07, 2021
The use of opioids for the treatment of pain is a risk versus benefit analysis and metabolic disease is an often overlooked variable in the equation and may lead to increased risk of comorbidities of ...
Jan 07, 2021
All four of the adenosine receptor (AR) subtypes mediate pain and have been targeted by pharmacologists to generate new therapeutics for chronic pain. The vanilloid phytochemicals, which include curcu...
Jan 07, 2021
Experience of childhood maltreatment (CM) is a risk factor for opioid use disorder (OUD). CM is also associated with comorbid mental disorders and poor treatment outcomes among people with OUD. To our...
Jan 07, 2021
Digital remote patient monitoring (RPM) can add value to virtual wards; this has become more apparent in the context of the COVID-19 pandemic. Healthcare providers are overwhelmed resulting in clinica...
Jan 07, 2021
The application of reclaimed asphalt pavement has been widely encouraged due to its significant economic and environmental benefits. However, it is necessary to add rejuvenators to ensure its performa...
Jan 07, 2021
Currently available data on the prescription practice among patients with major depressive disorder (MDD) reflect the outpatient setting. This is the first study to provide information on time trends ...
Jan 05, 2021
Understanding the neurobiological underpinnings of abstinence from drug abuse is critical to better recovery and ensure relapse prevention in addicted subjects. By comparing the long-term transcriptio...
Jan 05, 2021
Transcranial direct current stimulation (tDCS) is a safe, effective treatment for major depressive disorder (MDD). While antidepressant effects are heterogeneous, no studies have investigated trajecto...
Jan 05, 2021
Schizophrenia spectrum disorders (SSDs) and autism spectrum disorder (ASD) are associated with cognitive disabilities. The two conditions have historically been diagnosed separately using various test...
Jan 05, 2021
Several studies have demonstrated that early-onset depression is linked to poor health outcomes. However, whether it is related to specific diseases and premature death is not certain. This study aims...
Jan 05, 2021
Parkinson's Disease (PD) is a common neurodegenerative disorder associated with comorbidities and mental disorders. However, recent studies have indicated that PD could be associated with a higher ris...
Jan 04, 2021
This study aimed to improve the accuracy of bipolar disorder diagnoses by identifying symptoms that help to distinguish mania/hypomania in bipolar disorders from general 'happiness' in those with unip...
Jan 04, 2021
Despite heightened consumer interest in cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC), little is known about public perceptions regarding their medical use and potential for ab...
Jan 04, 2021
The suicide of a patient is a serious event that may constitute a therapeutic failure. To prevent these situations, national and international guidelines exist. When a suicide occurs in a psychiatric ...
Jan 04, 2021
Interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis (IPF) is currently treated with immunosuppressive therapy, with a dynamic algorithm based on continued clinical surveillance. P...
Jan 04, 2021
The discovery and development of safinamide, an alpha-aminoamide, has been a valuable addition to the existing clinical management of Parkinson's disease (PD). The journey of safinamide dates back to ...